Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (1-10 of 420) with videos related to

Pageof 42
Sort By:
Breast Cancer Research : BCR|December 22, 2010
Breast cancer prevention in the developing worldJack Cuzick
Breast Cancer Research : BCR|August 15, 2012
Breast density predicts endocrine treatment outcome in the adjuvant settingJack Cuzick
Lancet (London, England)|April 13, 2005
Forest plots and the interpretation of subgroupsJack Cuzick
The Lancet. Oncology|February 4, 2006
Keynote comment: Chemoprevention of cancer--time to catch up with the cardiologistsJack Cuzick
Breast Cancer (Tokyo, Japan)|January 29, 2008
Chemoprevention of breast cancerJack Cuzick
Statistics in Medicine|May 10, 2005
Interaction of statisticians with DMCsJack Cuzick
British Journal of Cancer|December 1, 2022
The importance of long-term follow up of participants in clinical trialsJack Cuzick
Breast Cancer Research : BCR|January 9, 2009
Assessing risk for breast cancerJack Cuzick
Expert Opinion on Therapeutic Targets|July 16, 2008
Use of LHRH-agonists as adjuvant therapy for breast cancerJack Cuzick
Lancet (London, England)|July 1, 2008
Primary endpoints for randomised trials of cancer therapyJack Cuzick
Pageof 42

Showing results (1-10 of 420) with videos related to

Sort By:
Pageof 42
Breast Cancer Research : BCR|December 22, 2010
Breast cancer prevention in the developing worldJack Cuzick
Breast Cancer Research : BCR|August 15, 2012
Breast density predicts endocrine treatment outcome in the adjuvant settingJack Cuzick
Lancet (London, England)|April 13, 2005
Forest plots and the interpretation of subgroupsJack Cuzick
The Lancet. Oncology|February 4, 2006
Keynote comment: Chemoprevention of cancer--time to catch up with the cardiologistsJack Cuzick
Breast Cancer (Tokyo, Japan)|January 29, 2008
Chemoprevention of breast cancerJack Cuzick
Statistics in Medicine|May 10, 2005
Interaction of statisticians with DMCsJack Cuzick
British Journal of Cancer|December 1, 2022
The importance of long-term follow up of participants in clinical trialsJack Cuzick
Breast Cancer Research : BCR|January 9, 2009
Assessing risk for breast cancerJack Cuzick
Expert Opinion on Therapeutic Targets|July 16, 2008
Use of LHRH-agonists as adjuvant therapy for breast cancerJack Cuzick
Lancet (London, England)|July 1, 2008
Primary endpoints for randomised trials of cancer therapyJack Cuzick
Pageof 42